TTY Biopharm Company is Biotechnology in Taiwan that focus on Biopharm Co Ltd business. Founded in 1960. They cover business area such as TTY Biopharm Co Ltd, marketing, pharmaceutical and chemical drug, Oncology, Health Care, Anti, Infection, Domestic Cardiovascular, Gastrointestinal Drugs, maximum revenue, Taiwan, a presence, european and other Countries, its product, Algitab, Alginos, Sulfin, Metacin, Cepiro, Brosym, Colimycin, Cubicin.
1960
( 64 years old in 2024 )
Biopharm Co Ltd
-
3F., No.3-1, Park Street
Taipei, Nangang 115-03
Taiwan
Private
TTY Biopharm Co Ltdmarketingpharmaceutical and chemical drugOncologyHealth CareAntiInfectionDomestic CardiovascularGastrointestinal Drugsmaximum revenueTaiwana presenceeuropean and other Countriesits productAlgitabAlginosSulfinMetacinCepiroBrosymColimycinCubicin
* We use standard office opening hours in near TTY Biopharm Company's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
TTY Biopharm Company is Biotechnology business from Taiwan that founded in 1960 (64 years old in 2024), TTY Biopharm Company business is focusing on Biopharm Co Ltd.
TTY Biopharm Company headquarter office and corporate office address is located in 3F., No.3-1, Park Street Taipei, Nangang 115-03 Taiwan.
TTY Biopharm Company was founded in Taiwan.
In 2024, TTY Biopharm Company is currently focus on Biopharm Co Ltd sector.
Above is snippet of Google Trends for "Biopharm Co Ltd" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with TTY Biopharm Company, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
